1、ANNUAL REPORT2018CONTENTSPagesCorporate Information2Management Discussion and Analysis3Biographical Details of Directors5Report of the Directors6Corporate Governance Report12Environmental,Social and Governance Report15Independent Auditors Report18Consolidated Statement of Profit or Loss and other co
2、mprehensive income20Consolidated Statement of Financial Position22Consolidated Statement of Changes in Equity23Consolidated Statement of Cash Flows24Notes to the Consolidated Financial Statements25Five Years Financial Summary54SoftMedx Healthcare Limited2CORPORATE INFORMATIONBOARD OF DIRECTORSExecut
3、ive DirectorCHEUNG Wai KwanWANG JianguoIndependent Non-executive DirectorsHU XuezhenLIN Pinzhuo(appointed on 2 February 2023)YIU Chun Wing(appointed on 20 December 2022)AUDIT COMMITTEEHU Xuezhen(Chairperson)LIN PinzhuoYIU Chun WingNOMINATION COMMITTEEHU Xuezhen(Chairperson)LIN PinzhuoYIU Chun WingRE
4、MUNERATION COMMITTEEHU Xuezhen(Chairperson)LIN PinzhuoYIU Chun WingRISK MANAGEMENT COMMITTEEYIU Chun Wing(Chairperson)LIN PinzhuoWANG JianguoCOMPANY SECRETARYLAM Sung Him,GastonSTOCK CODE648REGISTERED OFFICELevel 38,Infinitus Plaza,199 Des Voeux Road CentralHong KongSHARE REGISTRARTricor Tengis Limi
5、ted17/F,Far East Finance Centre16 Harcourt RoadHong KongPRINCIPAL BANKERSBank of China(Hong Kong)LimitedThe Hong Kong and Shanghai Bank Corporation LimitedINDEPENDENT AUDITORSCL Partners CPA LimitedCertified Public AccountantsWEBSITE ADDRESS.hkAnnual Report 20183MANAGEMENT DISCUSSION AND ANALYSISREV
6、IEW OF FINANCIAL RESULTSSoftMedx Healthcare Limited(the“Company”,together with its subsidiaries,the“Group”)is principally engaged in medical and well-being business.For the year ended 31 December 2018,the Group recorded revenue of HK$58.2 million(2017:HK$120.5 million),gross profit of HK$30.9 millio